Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
011500.KS Stock Summary
Top 10 Correlated ETFs
011500.KS
In the News
011500.KS Financial details
Company Rating
Buy
Market Cap
283.09B
Income
12.41B
Revenue
212.4B
Book val./share
10630.26
Cash/share
920.72
Dividend
120
Dividend %
0.74%
Employees
201
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
32.14
Forward P/E
-
PEG
7.17
P/S
1.32
P/B
1.54
P/C
18.7
P/FCF
24.08
Quick Ratio
2.09
Current Ratio
3.31
Debt / Equity
0.26
LT Debt / Equity
0.18
-
-
EPS (TTM)
811.64
EPS next Y
-
EPS next Q
-
EPS this Y
44.66%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
4.44%
Revenue last 5Y
0.74%
Revenue Q/Q
3.18%
EPS Q/Q
-130.78%
-
-
-
-
SMA20
-23.27%
SMA50
21.97%
SMA100
56.84%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
5%
ROC
-0.03%
Gross Margin
2%
Oper. Margin
-3%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10150.0-31850.0
52W High
-45.93%
52W Low
+69.66%
RSI
35.27
Rel Volume
0.07
Avg Volume
1.95M
Volume
143.76K
Perf Week
-9.65%
Perf Month
-20.83%
Perf Quarter
54.16%
Perf Half Y
43.02%
-
-
-
-
Beta
1.12
-
-
Volatility
618.45%, 2398.98%
Prev Close
-2.71%
Price
17220
Change
1.83%
011500.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 13.38K | 13.62K | 17.58K | 15.66K | 13.89K | |
Net income per share | 652.43 | 849.09 | 1.29K | 560.43 | 810.72 | |
Operating cash flow per share | 1.23K | 1.45K | -61.58 | 1.14K | 1.95K | |
Free cash flow per share | 771.6 | 185.54 | -1.32K | -616.75 | 1.09K | |
Cash per share | 585.03 | 257.67 | 315.15 | 199.34 | 920.72 | |
Book value per share | 7.86K | 8.56K | 9.66K | 9.98K | 10.63K | |
Tangible book value per share | 7.84K | 8.53K | 9.61K | 9.93K | 10.59K | |
Share holders equity per share | 7.86K | 8.56K | 9.66K | 9.98K | 10.63K | |
Interest debt per share | 1.56K | 1.09K | 2.51K | 3.3K | 2.87K | |
Market cap | 65.08B | 136.12B | 249.29B | 151.26B | 249.29B | |
Enterprise value | 84.74B | 149.54B | 283.37B | 197.91B | 280.08B | |
P/E ratio | 6.52 | 10.48 | 12.66 | 17.65 | 20.11 | |
Price to sales ratio | 0.32 | 0.65 | 0.93 | 0.63 | 1.17 | |
POCF ratio | 3.45 | 6.16 | -264.69 | 8.64 | 8.34 | |
PFCF ratio | 5.51 | 47.97 | -12.36 | -16.04 | 15.02 | |
P/B Ratio | 0.54 | 1.04 | 1.69 | 0.99 | 1.53 | |
PTB ratio | 0.54 | 1.04 | 1.69 | 0.99 | 1.53 | |
EV to sales | 0.41 | 0.72 | 1.05 | 0.83 | 1.32 | |
Enterprise value over EBITDA | 4.02 | 6.27 | 8.53 | 10.16 | 31.04 | |
EV to operating cash flow | 4.49 | 6.76 | -300.87 | 11.3 | 9.38 | |
EV to free cash flow | 7.18 | 52.7 | -14.05 | -20.98 | 16.87 | |
Earnings yield | 0.15 | 0.1 | 0.08 | 0.06 | 0.05 | |
Free cash flow yield | 0.18 | 0.02 | -0.08 | -0.06 | 0.07 | |
Debt to equity | 0.19 | 0.12 | 0.26 | 0.32 | 0.26 | |
Debt to assets | 0.14 | 0.09 | 0.17 | 0.22 | 0.18 | |
Net debt to EBITDA | 0.93 | 0.56 | 1.03 | 2.39 | 3.41 | |
Current ratio | 2.55 | 2.67 | 2.13 | 3.28 | 3.08 | |
Interest coverage | 16.59 | 26.67 | 35.52 | 7.55 | -1.16 | |
Income quality | 1.89 | 1.7 | -0.05 | 2.04 | 2.42 | |
Dividend Yield | 0.03 | 0.02 | 0.01 | 0.02 | 0.01 | |
Payout ratio | 0.18 | 0.18 | 0.14 | 0.41 | 0.15 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0 | 0.01 | 0.01 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.37 | -0.87 | 20.42 | -1.54 | -0.44 | |
Capex to revenue | -0.03 | -0.09 | -0.07 | -0.11 | -0.06 | |
Capex to depreciation | -1.03 | -2.54 | -2.3 | -2.77 | -1.16 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 10.74K | 12.78K | 16.73K | 11.22K | 13.93K | |
ROIC | 0.06 | 0.08 | 0.08 | 0.04 | -0.01 | |
Return on tangible assets | 0.06 | 0.08 | 0.09 | 0.04 | 0.05 | |
Graham Net | 635.87 | 607.71 | -14.27 | -317.19 | -442.37 | |
Working capital | 45.46B | 45.33B | 55.21B | 72.75B | 66.44B | |
Tangible asset value | 119.85B | 130.43B | 147.02B | 151.9B | 161.9B | |
Net current asset value | 31.76B | 32.03B | 34.84B | 31.86B | 23.59B | |
Invested capital | 0.19 | 0.12 | 0.26 | 0.32 | 0.26 | |
Average receivables | 44.28B | 44.96B | 52.3B | 57.38B | 52.02B | |
Average payables | 11.63B | 12.13B | 15.07B | 14.9B | 13.51B | |
Average inventory | 23.69B | 22.3B | 31.65B | 43.08B | 40.84B | |
Days sales outstanding | 77.83 | 81.1 | 79.19 | 86.03 | 81.8 | |
Days payables outstanding | 20 | 28.36 | 24.48 | 22.77 | 23.51 | |
Days of inventory on hand | 44.48 | 44.43 | 63.15 | 73.92 | 65.46 | |
Receivables turnover | 4.69 | 4.5 | 4.61 | 4.24 | 4.46 | |
Payables turnover | 18.25 | 12.87 | 14.91 | 16.03 | 15.53 | |
Inventory turnover | 8.21 | 8.22 | 5.78 | 4.94 | 5.58 | |
ROE | 0.08 | 0.1 | 0.13 | 0.06 | 0.08 | |
Capex per share | -462.12 | -1.26K | -1.26K | -1.76K | -867.95 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2K | 3.56K | 3.3K | 3.46K | 3.57K | |
Net income per share | -147.72 | -47.55 | 1.21K | -512.81 | 157.83 | |
Operating cash flow per share | 161.22 | -124.36 | 1.58K | 233.39 | 163.73 | |
Free cash flow per share | -231.6 | -42.86 | 978.97 | -28.78 | 174.56 | |
Cash per share | 199.34 | 295.3 | 799.3 | 620.56 | 920.72 | |
Book value per share | 9.98K | 9.81K | 11.05K | 10.58K | 10.63K | |
Tangible book value per share | 9.93K | 9.76K | 11K | 10.53K | 10.59K | |
Share holders equity per share | 9.98K | 9.81K | 11.05K | 10.58K | 10.63K | |
Interest debt per share | 3.25K | 3.42K | 2.95K | 2.9K | 2.77K | |
Market cap | 151.26B | 316.59B | 277.74B | 195.76B | 249.29B | |
Enterprise value | 197.91B | 364.42B | 310.5B | 230.6B | 280.08B | |
P/E ratio | -16.74 | -108.84 | 3.74 | -6.24 | 25.82 | |
Price to sales ratio | 4.95 | 5.82 | 5.5 | 3.7 | 4.57 | |
POCF ratio | 61.34 | -166.46 | 11.5 | 54.84 | 99.55 | |
PFCF ratio | -42.7 | -482.97 | 18.55 | -444.76 | 93.38 | |
P/B Ratio | 0.99 | 2.11 | 1.64 | 1.21 | 1.53 | |
PTB ratio | 0.99 | 2.11 | 1.64 | 1.21 | 1.53 | |
EV to sales | 6.48 | 6.7 | 6.15 | 4.36 | 5.13 | |
Enterprise value over EBITDA | -368.23 | 140.74 | 366.33 | -66.49 | 86.59 | |
EV to operating cash flow | 80.26 | -191.6 | 12.86 | 64.61 | 111.85 | |
EV to free cash flow | -55.87 | -555.94 | 20.74 | -523.92 | 104.91 | |
Earnings yield | -0.01 | 0 | 0.07 | -0.04 | 0.01 | |
Free cash flow yield | -0.02 | 0 | 0.05 | 0 | 0.01 | |
Debt to equity | 0.32 | 0.35 | 0.26 | 0.27 | 0.26 | |
Debt to assets | 0.22 | 0.22 | 0.18 | 0.19 | 0.18 | |
Net debt to EBITDA | -86.8 | 18.47 | 38.65 | -10.05 | 9.52 | |
Current ratio | 3.28 | 2.64 | 3.08 | 3.31 | 3.08 | |
Interest coverage | -7.22 | -0.31 | -3.74 | 0.09 | 0.48 | |
Income quality | -2.14 | 2.57 | 1.3 | -0.46 | 1.04 | |
Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
Payout ratio | 0 | 0 | 0.1 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0 | 0.06 | 0.01 | 0.01 | |
Research and developement to revenue | 0.02 | 0.01 | 0.01 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -2.44 | -0.66 | -0.38 | -1.12 | 0.07 | |
Capex to revenue | -0.2 | 0.02 | -0.18 | -0.08 | 0 | |
Capex to depreciation | -2.06 | 0.45 | -3.28 | -0.67 | 0.06 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.76K | 3.24K | 17.37K | 11.05K | 6.14K | |
ROIC | -0.01 | 0 | -0.01 | 0 | 0 | |
Return on tangible assets | -0.01 | 0 | 0.07 | -0.03 | 0.01 | |
Graham Net | -317.19 | -589.36 | -1.23K | -634.42 | -442.37 | |
Working capital | 72.75B | 68.69B | 60.8B | 66.84B | 66.44B | |
Tangible asset value | 151.9B | 149.33B | 168.3B | 161.06B | 161.9B | |
Net current asset value | 31.86B | 29.12B | 9.76B | 20.68B | 23.59B | |
Invested capital | 0.32 | 0.35 | 0.26 | 0.27 | 0.26 | |
Average receivables | 51.73B | 57.9B | 50.36B | 46.17B | 49.29B | |
Average payables | 13.85B | 15.21B | 12.98B | 10.4B | 12.22B | |
Average inventory | 45.41B | 45.91B | 41.57B | 35.9B | 35.88B | |
Days sales outstanding | 166.34 | 98.18 | 73.71 | 86.73 | 78.5 | |
Days payables outstanding | 38.79 | 28.5 | 17.16 | 20.42 | 22.91 | |
Days of inventory on hand | 125.93 | 80.52 | 66.18 | 63.6 | 63.78 | |
Receivables turnover | 0.54 | 0.92 | 1.22 | 1.04 | 1.15 | |
Payables turnover | 2.32 | 3.16 | 5.25 | 4.41 | 3.93 | |
Inventory turnover | 0.71 | 1.12 | 1.36 | 1.42 | 1.41 | |
ROE | -0.01 | 0 | 0.11 | -0.05 | 0.01 | |
Capex per share | -392.82 | 81.5 | -599.83 | -262.17 | 10.82 |
011500.KS Frequently Asked Questions
What is Hannong Chemicals Inc. stock symbol ?
Hannong Chemicals Inc. is a KR stock and trading under the symbol 011500.KS
What is Hannong Chemicals Inc. stock quote today ?
Hannong Chemicals Inc. stock price is $17220 today.
Is Hannong Chemicals Inc. stock public?
Yes, Hannong Chemicals Inc. is a publicly traded company.